Catalyst Wire Dossier Catalyst Wire Dossier

Autologous Expanded Natural Killer Cell Therapy

autologous expanded natural killer cells · University of Arkansas
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Expanded Natural Killer Cell Therapy, covering 2017-04-17 to 2017-04-17. Get the full timeline:

Most recent: Clinical Trial Update: UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma [Phase 2]

See pricing